Epothilones as Natural Compounds for Novel Anticancer Drugs Development.
anticancer agents
clinical trials
cytotoxicity
epothilone derivates
epothilones
refractory cancer
taxanes
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
23 Mar 2023
23 Mar 2023
Historique:
received:
31
01
2023
revised:
07
03
2023
accepted:
11
03
2023
medline:
14
4
2023
entrez:
13
4
2023
pubmed:
14
4
2023
Statut:
epublish
Résumé
Epothilone is a natural 16-membered macrolide cytotoxic compound produced by the metabolism of the cellulose-degrading myxobacterium
Identifiants
pubmed: 37047035
pii: ijms24076063
doi: 10.3390/ijms24076063
pmc: PMC10093981
pii:
doi:
Substances chimiques
ixabepilone
K27005NP0A
Epothilones
0
Capecitabine
6804DJ8Z9U
Antineoplastic Agents
0
Tubulin Modulators
0
Paclitaxel
P88XT4IS4D
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Agencia Nacional de Investigación y Desarrollo
ID : 1220831
Références
Clin Breast Cancer. 2015 Feb;15(1):8-15
pubmed: 25218708
Toxicol In Vitro. 2014 Jun;28(4):675-83
pubmed: 24583341
Drug Resist Updat. 2021 Jan;54:100742
pubmed: 33429249
J Clin Oncol. 2012 Nov 1;30(31):3841-7
pubmed: 22987083
Neuro Oncol. 2014 Apr;16(4):579-83
pubmed: 24470546
Future Med Chem. 2018 Jun 1;10(12):1483-1496
pubmed: 29788770
J Org Chem. 2020 Mar 6;85(5):2865-2917
pubmed: 32065746
Curr Med Chem Anticancer Agents. 2002 Jan;2(1):123-48
pubmed: 12678754
Clin Cancer Res. 2010 Mar 1;16(5):1634-41
pubmed: 20179242
J Clin Oncol. 2010 Jul 10;28(20):3256-63
pubmed: 20530276
J Microbiol Biotechnol. 2015 Oct;25(10):1653-9
pubmed: 25951845
Ann Oncol. 2012 Jan;23(1):53-58
pubmed: 21765178
Int J Pharm. 2017 Jun 30;526(1-2):474-495
pubmed: 28501439
IDrugs. 2003 Dec;6(12):1182-7
pubmed: 14666430
BMC Cancer. 2017 Jan 5;17(1):10
pubmed: 28056859
J Org Chem. 2013 Nov 1;78(21):10588-95
pubmed: 24079664
Chin J Nat Med. 2020 Dec;18(12):890-897
pubmed: 33357719
Breast Cancer Res Treat. 2015 Nov;154(2):299-308
pubmed: 26507191
J Nat Prod. 2001 Jul;64(7):847-56
pubmed: 11473410
Enzyme Microb Technol. 2021 Feb;143:109718
pubmed: 33375978
Breast Cancer Res Treat. 2017 Aug;164(3):649-658
pubmed: 28508185
Chem Biol Drug Des. 2020 Aug;96(2):768-772
pubmed: 32167676
Oncologist. 2008 Mar;13(3):214-21
pubmed: 18378531
J Clin Oncol. 2014 Oct 10;32(29):3307-29
pubmed: 25185096
J Clin Oncol. 2007 Aug 10;25(23):3448-55
pubmed: 17606973
Chemistry. 2004 May 17;10(10):2529-47
pubmed: 15146525
Clin Cancer Res. 2008 Mar 15;14(6):1618-24
pubmed: 18347162
Chemistry. 2001 Apr 17;7(8):1691-702
pubmed: 11349910
Int Rev Cell Mol Biol. 2020;351:57-99
pubmed: 32247582
ACS Chem Biol. 2017 Jul 21;12(7):1805-1812
pubmed: 28467833
Nat Rev Cancer. 2002 Jan;2(1):48-58
pubmed: 11902585
J Biol Chem. 1997 Jan 24;272(4):2534-41
pubmed: 8999970
Curr Pharm Des. 2005;11(13):1595-613
pubmed: 15892665
Cancer. 2015 Dec 1;121(23):4165-72
pubmed: 26308485
Cancer Invest. 2015 Jul;33(6):213-24
pubmed: 25919223
Gastrointest Cancer Res. 2012 Sep;5(5):155-60
pubmed: 23112883
Mol Cancer Ther. 2007 Oct;6(10):2786-97
pubmed: 17938270
J Med Chem. 2016 Apr 14;59(7):3499-514
pubmed: 26986898
Chem Biol. 2004 Feb;11(2):225-36
pubmed: 15123284
Gynecol Oncol. 2017 Jan;144(1):101-106
pubmed: 28029447
ACS Med Chem Lett. 2017 May 01;8(7):701-704
pubmed: 28740601
Invest New Drugs. 2013 Oct;31(5):1339-44
pubmed: 23801302
J Clin Oncol. 2007 Aug 10;25(23):3415-20
pubmed: 17606972
ACS Synth Biol. 2020 Aug 21;9(8):2009-2022
pubmed: 32603592
Ann Oncol. 2021 Feb;32(2):218-228
pubmed: 33188874
Environ Toxicol Pharmacol. 2015 Mar;39(2):700-12
pubmed: 25721485
J Natl Compr Canc Netw. 2021 Feb 02;19(2):134-143
pubmed: 33545689
Int J Oncol. 1997 Jul;11(1):123-6
pubmed: 21528189
Cell Death Dis. 2021 Apr 1;12(4):338
pubmed: 33795638
Cancers (Basel). 2020 Nov 10;12(11):
pubmed: 33182737
Mol Biotechnol. 2023 Feb;65(2):282-289
pubmed: 36401710
Am J Health Syst Pharm. 2008 Nov 1;65(21):2017-26
pubmed: 18945860
Ann Oncol. 2007 Jul;18 Suppl 5:v22-7
pubmed: 17656558
J Hematol Oncol. 2016 Aug 11;9(1):68
pubmed: 27516093
Org Lett. 2012 Dec 21;14(24):6354-7
pubmed: 23214997
Breast Cancer. 2017 Mar;24(2):171-179
pubmed: 27491426
Cancer Res. 2002 Jul 15;62(14):4081-8
pubmed: 12124345
Chem Biol. 2001 Sep;8(9):899-912
pubmed: 11564558
Ann Oncol. 2009 Mar;20(3):492-7
pubmed: 19087985
Front Oncol. 2021 Jul 06;11:617874
pubmed: 34295806
J Antibiot (Tokyo). 1996 Jun;49(6):560-3
pubmed: 8698639
Toxicol In Vitro. 2013 Feb;27(1):239-49
pubmed: 22995584
Expert Opin Investig Drugs. 2011 Jan;20(1):107-17
pubmed: 21142807
Expert Opin Ther Pat. 2016 Aug;26(8):891-905
pubmed: 27282355
J Pain Symptom Manage. 2011 Dec;42(6):931-40
pubmed: 21621965
ChemMedChem. 2015 Dec;10(12):1974-9
pubmed: 26447977
Lancet Oncol. 2017 Mar;18(3):279-281
pubmed: 28209299
Cancer Res. 1995 Jun 1;55(11):2325-33
pubmed: 7757983
Angew Chem Int Ed Engl. 1998 Aug 17;37(15):2014-2045
pubmed: 29711063
J Clin Oncol. 2009 Jul 1;27(19):3097-103
pubmed: 19451434
Biochemistry. 2001 Jul 10;40(27):8000-8
pubmed: 11434769
Semin Oncol. 2005 Dec;32(6 Suppl 7):S22-6
pubmed: 16360719
Cancer Res. 2003 Sep 15;63(18):6026-31
pubmed: 14522931
Neuro Oncol. 2011 Sep;13(9):1000-10
pubmed: 21743064
Oncology. 2015;88(3):180-8
pubmed: 25472499
Breast Cancer Res Treat. 2010 Jun;121(2):261-71
pubmed: 20229176
Colloids Surf B Biointerfaces. 2016 Apr 1;140:403-411
pubmed: 26780253
Front Bioeng Biotechnol. 2019 Nov 26;7:334
pubmed: 32039165
Angew Chem Int Ed Engl. 2002 Apr 15;41(8):1381-3
pubmed: 19750771
ChemMedChem. 2007 Jul;2(7):920-42
pubmed: 17530726
Lung Cancer. 2012 Oct;78(1):70-5
pubmed: 22947511
Clin Breast Cancer. 2007 Apr;7(7):543-9
pubmed: 17509162
Oncology. 2012;83(1):1-9
pubmed: 22688083
Prostate. 2004 Nov 1;61(3):243-7
pubmed: 15368466
Science. 2013 Feb 1;339(6119):587-90
pubmed: 23287720
Clin Breast Cancer. 2018 Dec;18(6):489-497
pubmed: 30153978
Cancer Chemother Pharmacol. 2011 Oct;68(4):971-8
pubmed: 21305287
Curr Top Med Chem. 2014;14(20):2312-21
pubmed: 25434353
Anticancer Drugs. 2014 May;25(5):599-609
pubmed: 24398663
Science. 2015 Apr 17;348(6232):347-52
pubmed: 25765066
J Am Chem Soc. 2017 May 31;139(21):7318-7334
pubmed: 28513142
Mol Cancer Ther. 2009 Feb;8(2):275-81
pubmed: 19174552
Cancer. 1995 Mar 1;75(5):1141-50
pubmed: 7850713
Angew Chem Int Ed Engl. 2003 Jun 6;42(22):2521-5
pubmed: 12800176
J Clin Oncol. 2007 Nov 20;25(33):5210-7
pubmed: 17968020
Mol Pharmacol. 2008 Oct;74(4):1072-83
pubmed: 18593821
Biochim Biophys Acta. 1999 May 14;1445(2):185-95
pubmed: 10320771
J Clin Oncol. 2005 Dec 20;23(36):9048-50
pubmed: 16301592
Clin Cancer Res. 2001 May;7(5):1429-37
pubmed: 11350914
Molecules. 2016 Aug 03;21(8):
pubmed: 27527129
Cancer Chemother Pharmacol. 2008 Nov;62(6):1045-54
pubmed: 18301895
Crit Rev Oncol Hematol. 2012 Apr;82(1):51-77
pubmed: 21908200
Bioorg Med Chem. 2018 Nov 1;26(20):5578-5581
pubmed: 30318441
Br J Cancer. 2022 Jun;126(12):1695-1703
pubmed: 35149854
Prostate. 2005 Nov 1;65(3):231-40
pubmed: 15948135
Biochem Biophys Res Commun. 2021 Jan 1;534:330-336
pubmed: 33272565
Anticancer Drugs. 2018 Aug;29(7):691-701
pubmed: 29734209
Gynecol Oncol. 2003 Apr;89(1):37-47
pubmed: 12694652
Blood. 2005 Jan 1;105(1):350-7
pubmed: 15367426